Sr. Director - Aesthetic Health External Innovation

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve.

This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you also can count on us to develop creative solutions to support communities through philanthropy and volunteerism.

Aesthetic Health is an emerging and strategically important area at Lilly, sitting at the intersection of immunology, dermatology, and metabolic medicine. With a growing portfolio and a patient population increasingly searching for visible health solutions, external innovation will be central to building a differentiated, science-driven aesthetic medicine capability.

Reporting to the SVP, Immunology Research, and working in close partnership with Corporate BD, Catalyze
360, Aesthetic Health Strategy and Discovery colleagues, the Executive Director, Aesthetic Health External Innovation role provides search and evaluate activities for external and academic programs in aesthetic medicine — identifying, evaluating, and executing transformative partnerships across cutaneous biology, body contouring, skin aging, hair biology, and adjacent aesthetic indications. This role serves as the primary scientific interface between Lilly’s internal aesthetic health strategy and the external innovation ecosystem, ensuring that the most compelling external science is identified early and licensed or acquired with appropriate urgency to meet our Aesthetic Health strategic objectives.

The successful candidate will combine deep mechanistic expertise with strategic judgment, relationship breadth, and an ability to operate effectively across scientific, clinical, commercial, and financial stakeholders.

• Source, identify, and coordinate evaluation of innovative external assets for Aesthetic Health, spanning the full range of modalities — from biologics and small molecules to devices and device-drug combinations, and novel delivery platforms — with a focus on differentiated and non-obvious solutions that can reshape the treatment landscape
• Drive deals to completion completion: this role is expected to directly in-source programs into Lilly's Aesthetic Health portfolio (working with corporate business development and other functions), and the ability to align internal stakeholders, build consensus, and close transactions is a core expectation
• Build long‑term trusted relationships and serve as Lilly Aesthetic Health's representative with external partners, investment groups, and academic innovators, as well as internal peers and collaborators across Aesthetic Health and discovery, development, and commercial functions
• Actively engage and examine the global innovation ecosystem — including emerging biotechs, medical device companies, academic spinouts, and adjacent consumer health innovators — for partnering, licensing, and acquisition possibilities that augment Lilly's Aesthetic Health capabilities and pipeline
• Lead interactions with selected external organizations; represent…